- Home
- NPB vs HRTX Comparison
NPB vs HRTX Comparison
Compare NPB & HRTX Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- NPB
- HRTX
- Stock Information
- Founded
- NPB 1999
- HRTX 1983
- Country
- NPB United States
- HRTX United States
- Employees
- NPB N/A
- HRTX N/A
- Industry
- NPB
- HRTX Biotechnology: Pharmaceutical Preparations
- Sector
- NPB
- HRTX Health Care
- Exchange
- NPB NYSE
- HRTX Nasdaq
- Market Cap
- NPB 421.7M
- HRTX 350.4M
- IPO Year
- NPB 2025
- HRTX 1987
- Fundamental
- Price
- NPB $13.74
- HRTX $2.11
- Analyst Decision
- NPB Buy
- HRTX Strong Buy
- Analyst Count
- NPB 2
- HRTX 2
- Target Price
- NPB $17.25
- HRTX $5.50
- AVG Volume (30 Days)
- NPB 136.3K
- HRTX 1.8M
- Earning Date
- NPB 01-01-0001
- HRTX 05-06-2025
- Dividend Yield
- NPB 0.19%
- HRTX N/A
- EPS Growth
- NPB 108.67
- HRTX N/A
- EPS
- NPB 1.94
- HRTX N/A
- Revenue
- NPB $191,534,000.00
- HRTX $148,518,000.00
- Revenue This Year
- NPB $23.72
- HRTX $11.18
- Revenue Next Year
- NPB $14.51
- HRTX $13.15
- P/E Ratio
- NPB $7.00
- HRTX N/A
- Revenue Growth
- NPB N/A
- HRTX 12.43
- 52 Week Low
- NPB $11.43
- HRTX $1.04
- 52 Week High
- NPB $14.98
- HRTX $3.93
- Technical
- Relative Strength Index (RSI)
- NPB N/A
- HRTX 47.04
- Support Level
- NPB N/A
- HRTX $2.00
- Resistance Level
- NPB N/A
- HRTX $2.61
- Average True Range (ATR)
- NPB 0.00
- HRTX 0.18
- MACD
- NPB 0.00
- HRTX -0.01
- Stochastic Oscillator
- NPB 0.00
- HRTX 20.63
About NPB NORTHPOINTE BANCSHARES INC
Northpointe Bancshares Inc operates its business through its wholly-owned banking subsidiary, Its lending focus is the origination of residential mortgages throughout the United States. The majority of these loans are sold in the secondary market through a network of investors. The Company has also developed mortgage advance program that provides funding to pre-approved mortgage bankers who originate and sell individual conforming and non-qualified loan products in the secondary market. The Company continues to service loans that were originated and sold to investors as well as loans held in its portfolio which were originated and selectively held in portfolio.
About HRTX Heron Therapeutics Inc.
Heron Therapeutics Inc is a commercial-stage biotechnology company. It is focused on improving the lives of patients by developing treatments that address some of the unmet patient needs. The company's product portfolio consists of APONVIE, SUSTOL, ZYNRELEF, and CINVANTI.